Get the latest Science News and Discoveries

AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses

CEPI to expand collaboration with Gennova Biopharmaceuticals Limited, providing up to US$13.38 million to advance the development of a vaccine candidate against Nipah virus using their self-amplifying mRNA vaccine technology. - Gennova will also work with Houston Methodist Research Institute to apply cutting-edge AI technology to identify potential Nipah vaccine targets.

None

Get the Android app